RadComp试验中接受综合淋巴结照射的非转移性乳腺癌患者报告结局的验证
本研究评估RadComp实用性随机临床试验中11项患者报告结局(PRO)测量工具的心理测量学特性,纳入774名完成6个月治疗后评估的英语女性参与者。多数PRO与效度指标相关性≥0.5,已知组效度和敏感性分析支持这些工具具有较高信度和效度,可用于反映放疗对健康相关生活质量的影响。
要点
- 多数PRO与效度指标相关性较大(≥0.5),支持其聚合效度。
- 乳房切除者乳房外观满意度评分低于肿块切除者(P<.001)。
- 基线体能状态好者FACT-B Trial Outcome Index及PROMIS疲乏、社会角色参与评分更优(P<.05)。
核心结论
- 对于RadComp实用性随机临床试验中接受放疗的非转移性乳腺癌患者,本研究发现重要PRO测量工具具有较高信度和效度,支持其心理测量学强度及反映放疗对健康相关生活质量影响的有用性。
研究设计与样本
- 研究为对RadComp实用性随机临床试验中去标识盲法数据集的分析,纳入774名完成6个月治疗后评估的英语女性参与者。
- 评估了11项PRO测量工具,包括FACT-B的Trial Outcome Index、乳房外观满意度、BREAST-Q及选定的PROMIS测量工具,在基线、放疗完成时和放疗后6个月三个时间点测量。
- 使用10个变量作为效度锚,计算Pearson或Spearman相关系数,采用方差分析比较临床不同类别间的PRO均值差异,并将PRO变化评分映射至其他变量变化。
主要发现
- 多数PRO与效度指标之间的相关性较大(≥0.5)。
- 乳房外观满意度平均评分在肿块切除者中高于乳房切除者(P<.001)。
- FACT-B Trial Outcome Index及PROMIS疲乏和社会角色与活动参与能力平均评分在基线体能状态好者中优于较差者(P<.05)。
- 在放疗完成时和放疗后,乳房外观满意度及BREAST-Q Radiation平均评分在所有FACT-TS-G条目类别间差异显著(P<.001)。
- FACT-B Trial Outcome Index、疲乏、焦虑及社会角色参与变化评分与视觉模拟量表变化评分之间存在中等大小相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our purpose was to evaluate the measurement properties of patient-reported outcome (PRO) measures used in the ongoing RadComp pragmatic randomized clinical trial (PRCT). METHODS AND MATERIALS: The deidentified and blinded data set included 774 English-speaking female participants who completed their 6-month posttreatment assessment. Eleven PRO measures were evaluated, including the Trial Outcome Index from the Functional Assessment of Cancer Therapy-Breast (FACT-B), Satisfaction with Breast Cosmetic Outcomes, the BREAST-Q, and selected Patient-Reported Outcomes Measurement Information System (PROMIS) measures. PROs were measured at 3 timepoints: baseline, completion of radiation therapy (RT), and 6 months post-RT. Ten variables were used as validity anchors. Pearson or Spearman correlations were calculated between PROs and convergent validity indicators. Mean PRO differences between clinically distinct categories were compared with analysis of variance methods (known-groups validity). PRO change scores were mapped to change in other variables (sensitivity to change). RESULTS: Most correlations between PROs and validity indicators were large (≥0.5). Mean score for Satisfaction with Breast Cosmetic Outcomes was higher (better) for those with a lumpectomy compared with those with a mastectomy (P < .001). Mean scores for the FACT-B Trial Outcome Index and for PROMIS Fatigue and Ability to Participate in Social Roles and Activities were better for those with good baseline performance status compared with those with poorer baseline performance status (P < .05). At completion of RT and post-RT, mean scores for Satisfaction with Breast Cosmetic Outcomes and BREAST-Q Radiation were significantly different (P < .001) across categories for all Functional Assessment of Chronic Illness Therapy -Treatment Satisfaction - General items. There were medium-sized correlations between change scores for FACT-B Trial Outcome Index, Fatigue, Anxiety, and Ability to Participate in Social Roles and change scores in the Visual Analog Scale. CONCLUSIONS: For patients with nonmetastatic breast cancer receiving radiation in the RadComp PRCT, our findings demonstrate high reliability and validity for important PRO measures, supporting their psychometric strength and usefulness to reflect the effect of RT on health-related quality of life.
引用
- Hahn EA, Pugh SL, Lu HL, et al. Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial. Int J Radiat Oncol Biol Phys. 2024. PMID: 38739047. doi:10.1016/j.ijrobp.2024.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。